| NCT03367260 |
The Treatment Preferences of Women Diagnosed With Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03367260 |
Completed |
Duke University |
2019-01-04 |
| NCT03367182 |
Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03367182 |
Completed |
Yonsei University |
2018-01-31 |
| NCT03275298 |
Evolution of the Therapeutic Care in Ovarian Cancer From 2011 |
https://ClinicalTrials.gov/show/NCT03275298 |
Recruiting |
UNICANCER |
2019-12-31 |
| NCT03155451 |
Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer. |
https://ClinicalTrials.gov/show/NCT03155451 |
Completed |
RenJi Hospital |
2017-10-18 |
| NCT03131102 |
Perioperative Early Tiredness (Acute Fatigue) in Patients With Epithelial Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03131102 |
Recruiting |
Charite University, Berlin, Germany |
2020-04-30 |
| NCT03119285 |
Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype Families |
https://ClinicalTrials.gov/show/NCT03119285 |
Recruiting |
University of Washington |
2023-07-31 |
| NCT03082976 |
Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region |
https://ClinicalTrials.gov/show/NCT03082976 |
Completed |
AstraZeneca |
2019-07-24 |
| NCT03019315 |
The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients |
https://ClinicalTrials.gov/show/NCT03019315 |
Recruiting |
National Taiwan University Hospital |
2020-12-31 |
| NCT03015376 |
Inherited Susceptible Genes Among Epithelial Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03015376 |
Recruiting |
Peking Union Medical College Hospital |
2019-01-31 |
| NCT03004391 |
Development of a Decision Aid to Facilitate Ovarian Cancer Patient’s Choices Regarding Biomarker CA125 |
https://ClinicalTrials.gov/show/NCT03004391 |
Recruiting |
Vejle Hospital |
2020-06-30 |
| NCT02981901 |
Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France |
https://ClinicalTrials.gov/show/NCT02981901 |
Active, not recruiting |
Centre Leon Berard |
2019-12-31 |
| NCT02963688 |
BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02963688 |
Completed |
Samsung Medical Center |
2015-12-31 |
| NCT02952521 |
Ovarian Tumor Biopsies to Study Response to Treatments |
https://ClinicalTrials.gov/show/NCT02952521 |
Recruiting |
University Health Network, Toronto |
2021-05-31 |
| NCT02928549 |
Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study |
https://ClinicalTrials.gov/show/NCT02928549 |
Completed |
Memorial Sloan Kettering Cancer Center |
2019-08-26 |
| NCT02916875 |
Individual Survivorship Program for Ovarian Cancer Patients Based on PROM’s and Shared Decision Making |
https://ClinicalTrials.gov/show/NCT02916875 |
Active, not recruiting |
Vejle Hospital |
2018-12-31 |
| NCT02910622 |
Pilot Study Evaluating the Oncogramme: Analysis of Response to Induction Treatment of Patients With Breast or Ovarian Cancer. |
https://ClinicalTrials.gov/show/NCT02910622 |
Completed |
University Hospital, Limoges |
2016-06-30 |
| NCT02786147 |
Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02786147 |
Completed |
Emory University |
2018-02-28 |
| NCT02785731 |
Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass. |
https://ClinicalTrials.gov/show/NCT02785731 |
Completed |
Angle plc |
2017-10-09 |
| NCT02758652 |
Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02758652 |
Recruiting |
Tampere University Hospital |
2026-04-30 |
| NCT02973750 |
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02973750 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2021-01-31 |
| NCT00043472 |
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk |
https://ClinicalTrials.gov/show/NCT00043472 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00040222 |
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT00040222 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT03203993 |
China Ovarian Cancer BRCA Testing Study |
https://ClinicalTrials.gov/show/NCT03203993 |
Recruiting |
AstraZeneca |
2026-03-31 |
| NCT04135521 |
Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT04135521 |
Completed |
Far Eastern Memorial Hospital |
2020-03-31 |
| NCT00086567 |
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers |
https://ClinicalTrials.gov/show/NCT00086567 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02489058 |
A Study of Long-Term Responders on Olaparib |
https://ClinicalTrials.gov/show/NCT02489058 |
Recruiting |
University Health Network, Toronto |
2020-07-31 |
| NCT02480790 |
Venous Thromboembolic Complications in Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02480790 |
Active, not recruiting |
Aalborg University Hospital |
2017-05-31 |
| NCT02394015 |
Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC |
https://ClinicalTrials.gov/show/NCT02394015 |
Completed |
Grupo Español de Investigación en Cáncer de Ovario |
2017-12-31 |
| NCT02393898 |
BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older |
https://ClinicalTrials.gov/show/NCT02393898 |
Completed |
Hoffmann-La Roche |
2019-06-14 |
| NCT02343510 |
Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot Study |
https://ClinicalTrials.gov/show/NCT02343510 |
Completed |
Ain Shams University |
2017-03-31 |
| NCT02341118 |
Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome. |
https://ClinicalTrials.gov/show/NCT02341118 |
Recruiting |
University Health Network, Toronto |
2020-05-31 |
| NCT02262273 |
OSCA - Olaparib Standard of CAre Study |
https://ClinicalTrials.gov/show/NCT02262273 |
Completed |
AstraZeneca |
2016-04-30 |
| NCT02258165 |
Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02258165 |
Active, not recruiting |
Queensland Centre for Gynaecological Cancer |
2020-08-31 |
| NCT02222883 |
Prevalence of BRCA in Patients With Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02222883 |
Active, not recruiting |
AGO Research GmbH |
2020-09-30 |
| NCT02151370 |
An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02151370 |
Completed |
Hoffmann-La Roche |
2013-09-30 |
| NCT02122588 |
OVArian Cancer Non-Interventional Study - OVATAR |
https://ClinicalTrials.gov/show/NCT02122588 |
Completed |
AstraZeneca |
2018-05-31 |
| NCT02063464 |
Blood Collection From People With Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02063464 |
Completed |
National Institutes of Health Clinical Center (CC) |
2016-03-14 |
| NCT01276574 |
Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT |
https://ClinicalTrials.gov/show/NCT01276574 |
Active, not recruiting |
Turku University Hospital |
2020-12-31 |
| NCT02043158 |
Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02043158 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-01-31 |
| NCT02016833 |
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity |
https://ClinicalTrials.gov/show/NCT02016833 |
Completed |
PX Biosolutions |
2014-06-30 |
| NCT03667417 |
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation |
https://ClinicalTrials.gov/show/NCT03667417 |
Recruiting |
Institut Paoli-Calmettes |
2028-10-15 |
| NCT02825420 |
Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients |
https://ClinicalTrials.gov/show/NCT02825420 |
Completed |
PharmaMar |
2019-08-31 |
| NCT01982500 |
Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01982500 |
Completed |
Hellenic Oncology Research Group |
2016-10-31 |
| NCT01932125 |
An Observational Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer |
https://ClinicalTrials.gov/show/NCT01932125 |
Recruiting |
Hoffmann-La Roche |
2020-11-30 |
| NCT01881451 |
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01881451 |
Active, not recruiting |
British Columbia Cancer Agency |
2016-03-31 |
| NCT01869400 |
An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01869400 |
Completed |
PharmaMar, Spain |
2016-12-31 |
| NCT01863693 |
An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1) |
https://ClinicalTrials.gov/show/NCT01863693 |
Completed |
Hoffmann-La Roche |
2018-06-15 |
| NCT01788995 |
BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01788995 |
Completed |
Hoffmann-La Roche |
2018-10-11 |
| NCT01591772 |
Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01591772 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-04-30 |
| NCT01544049 |
Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study |
https://ClinicalTrials.gov/show/NCT01544049 |
Completed |
University of Washington |
2018-09-04 |
| NCT01538498 |
Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01538498 |
Completed |
National Cancer Center, Korea |
2012-11-30 |
| NCT01505829 |
Diffusion-weighted Imaging Study in Cancer of the Ovary |
https://ClinicalTrials.gov/show/NCT01505829 |
Completed |
Institute of Cancer Research, United Kingdom |
2016-12-31 |
| NCT01471483 |
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01471483 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-11-30 |
| NCT01466049 |
New Biomarkers Evaluating Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01466049 |
Completed |
Fujirebio Diagnostics, Inc. |
2014-03-31 |
| NCT01422265 |
Patient Reported Symptoms in Ovarian Cancer (PRECISION) |
https://ClinicalTrials.gov/show/NCT01422265 |
Completed |
Genentech, Inc. |
2015-04-30 |
| NCT01384097 |
An Algorithm for Intra-operative Goal-directed Haemodynamic Management in Non-cardiac Surgery |
https://ClinicalTrials.gov/show/NCT01384097 |
Completed |
Charite University, Berlin, Germany |
2011-02-28 |
| NCT01372787 |
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer |
https://ClinicalTrials.gov/show/NCT01372787 |
Active, not recruiting |
Gynecologic Oncology Group |
2014-01-31 |
| NCT01366183 |
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer |
https://ClinicalTrials.gov/show/NCT01366183 |
Active, not recruiting |
Gynecologic Oncology Group |
2019-12-31 |
| NCT04414683 |
Factors Affecting the Prognosis of Early Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT04414683 |
Recruiting |
Far Eastern Memorial Hospital |
2022-01-31 |
| NCT04295577 |
Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR |
https://ClinicalTrials.gov/show/NCT04295577 |
Active, not recruiting |
Royal Marsden NHS Foundation Trust |
2022-02-03 |
| NCT04248231 |
CINSARC Genomic Signature as Predictor of Resectability of Ovarian Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT04248231 |
Recruiting |
Institut Claudius Regaud |
2020-09-15 |
| NCT04234243 |
HIPEC in Ovarian Cancer, Case-Controls Study With 10-years Follow up |
https://ClinicalTrials.gov/show/NCT04234243 |
Completed |
Instituto de Seguridad Social del Estado de Mexico y Municipios |
2017-12-31 |
| NCT04222465 |
Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients |
https://ClinicalTrials.gov/show/NCT04222465 |
Recruiting |
AstraZeneca |
2020-12-31 |
| NCT04191252 |
Genetic Mutation in Epithelial Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT04191252 |
Recruiting |
Peking Union Medical College Hospital |
2022-01-01 |
| NCT04190667 |
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT04190667 |
Recruiting |
Peking Union Medical College Hospital |
2021-12-07 |
| NCT04067960 |
Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer |
https://ClinicalTrials.gov/show/NCT04067960 |
Recruiting |
Mayo Clinic |
2020-12-31 |
| NCT03987555 |
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients |
https://ClinicalTrials.gov/show/NCT03987555 |
Recruiting |
Wake Forest University Health Sciences |
2021-03-31 |
| NCT03980028 |
Role of Surgery in Advanced Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03980028 |
Completed |
Institut Claudius Regaud |
2019-01-01 |
| NCT03943316 |
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies |
https://ClinicalTrials.gov/show/NCT03943316 |
Recruiting |
New Mexico Cancer Care Alliance |
2020-12-31 |
| NCT03931304 |
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2) |
https://ClinicalTrials.gov/show/NCT03931304 |
Completed |
Hospices Civils de Lyon |
2018-07-31 |
| NCT03921658 |
The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03921658 |
Recruiting |
University of Minnesota |
2022-10-31 |
| NCT03877796 |
Clinical Pre-screening Protocol for Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03877796 |
Recruiting |
Oncology Venture |
2021-09-30 |
| NCT03862677 |
Determining Prognostic Immune Markers in Patients With Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03862677 |
Recruiting |
Leiden University Medical Center |
2022-02-01 |
| NCT03837327 |
Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy |
https://ClinicalTrials.gov/show/NCT03837327 |
Recruiting |
Venn Biosciences Corporation |
2021-04-30 |
| NCT03742856 |
A Multi-omics Study of Epithelial Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03742856 |
Recruiting |
Peking Union Medical College Hospital |
2020-11-23 |
| NCT03742388 |
A Genomic Analysis of Evolution of Epithelia Ovarian Tumors |
https://ClinicalTrials.gov/show/NCT03742388 |
Recruiting |
Peking Union Medical College Hospital |
2020-12-23 |
| NCT03738319 |
Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03738319 |
Recruiting |
Peking Union Medical College Hospital |
2019-11-23 |
| NCT03707574 |
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study |
https://ClinicalTrials.gov/show/NCT03707574 |
Recruiting |
National Cancer Institute (NCI) |
2023-05-01 |
| NCT03691012 |
Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03691012 |
Recruiting |
Walter and Eliza Hall Institute of Medical Research |
2020-06-30 |
| NCT03656809 |
Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03656809 |
Active, not recruiting |
NYU Langone Health |
2019-03-01 |
| NCT03622385 |
Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03622385 |
Active, not recruiting |
Baylor Research Institute |
2020-10-31 |
| NCT03614689 |
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire |
https://ClinicalTrials.gov/show/NCT03614689 |
Recruiting |
Geneplus-Beijing Co. Ltd. |
2019-11-30 |
| NCT03505307 |
Lynparza Ovarian Cancer Clinical Experience Investigation (All Case Investigation) |
https://ClinicalTrials.gov/show/NCT03505307 |
Active, not recruiting |
AstraZeneca |
2020-07-31 |
| NCT03491033 |
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy |
https://ClinicalTrials.gov/show/NCT03491033 |
Completed |
Yonsei University |
2017-10-31 |
| NCT01096394 |
Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer |
https://ClinicalTrials.gov/show/NCT01096394 |
Completed |
Vanderbilt University |
2015-10-31 |
| NCT01080521 |
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT01080521 |
Completed |
Gynecologic Oncology Group |
2012-01-31 |
| NCT01042847 |
How Our Immune System Can Help Fight Cancer |
https://ClinicalTrials.gov/show/NCT01042847 |
Completed |
Winthrop University Hospital |
2015-02-28 |
| NCT01037751 |
M. D. Anderson Symptom Inventory - Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT01037751 |
Completed |
M.D. Anderson Cancer Center |
2018-07-18 |
| NCT01000259 |
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer |
https://ClinicalTrials.gov/show/NCT01000259 |
Recruiting |
Gynecologic Oncology Group |
2100-01-31 |
| NCT00987649 |
Ovarian Cancer Risk Estimation in Patients With Pelvic Mass |
https://ClinicalTrials.gov/show/NCT00987649 |
Completed |
Fujirebio Diagnostics, Inc. |
2010-08-31 |
| NCT00986206 |
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT00986206 |
Completed |
Women and Infants Hospital of Rhode Island |
2015-07-31 |
| NCT00946140 |
Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study |
https://ClinicalTrials.gov/show/NCT00946140 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-10-31 |
| NCT00900523 |
Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT00900523 |
Completed |
Vanderbilt-Ingram Cancer Center |
2007-07-31 |
| NCT00897442 |
Collecting Tumor Samples From Patients With Gynecological Tumors |
https://ClinicalTrials.gov/show/NCT00897442 |
Completed |
Gynecologic Oncology Group |
2016-01-31 |
| NCT00879840 |
Assessment of Screening Modalities for Gynecologic Cancers |
https://ClinicalTrials.gov/show/NCT00879840 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00829959 |
Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC) |
https://ClinicalTrials.gov/show/NCT00829959 |
Completed |
M.D. Anderson Cancer Center |
2016-08-31 |
| NCT00804258 |
Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT00804258 |
Completed |
City of Hope Medical Center |
2012-01-31 |
| NCT04204811 |
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy |
https://ClinicalTrials.gov/show/NCT04204811 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2020-12-16 |
| NCT02856841 |
The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02856841 |
Completed |
Cairo University |
2016-06-30 |
| NCT03164980 |
Comparison of QoL Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03164980 |
Recruiting |
North Eastern German Society of Gynaecological Oncology |
2022-02-28 |
| NCT03124212 |
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland |
https://ClinicalTrials.gov/show/NCT03124212 |
Recruiting |
University of Basel |
2024-03-31 |
| NCT04152941 |
Real-life Data of Olaparib in Relapsed Ovarian Cancers Patients |
https://ClinicalTrials.gov/show/NCT04152941 |
Active, not recruiting |
ARCAGY/ GINECO GROUP |
2020-01-31 |
| NCT03956095 |
Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT03956095 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-05-31 |
| NCT03939481 |
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT03939481 |
Recruiting |
Southwest Oncology Group |
2025-02-28 |
| NCT00787514 |
FR in Stored Plasma |
https://ClinicalTrials.gov/show/NCT00787514 |
Completed |
Royal Marsden NHS Foundation Trust |
2011-02-28 |
| NCT00757952 |
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction |
https://ClinicalTrials.gov/show/NCT00757952 |
Completed |
Pine Street Foundation |
2012-12-31 |
| NCT00735150 |
Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk |
https://ClinicalTrials.gov/show/NCT00735150 |
Completed |
Memorial Sloan Kettering Cancer Center |
2010-10-31 |
| NCT00711932 |
The Effect of TRA-8 on Ovarian Cancer Tissue |
https://ClinicalTrials.gov/show/NCT00711932 |
Completed |
University of Alabama at Birmingham |
2012-01-31 |
| NCT00684801 |
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers |
https://ClinicalTrials.gov/show/NCT00684801 |
Completed |
Case Comprehensive Cancer Center |
2011-12-31 |
| NCT00628654 |
Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants |
https://ClinicalTrials.gov/show/NCT00628654 |
Completed |
University of California, Davis |
2016-03-10 |
| NCT00596349 |
Women Surviving Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT00596349 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-02-28 |
| NCT00531570 |
Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma |
https://ClinicalTrials.gov/show/NCT00531570 |
Completed |
NYU Langone Health |
NA |
| NCT00525460 |
Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function |
https://ClinicalTrials.gov/show/NCT00525460 |
Completed |
Dana-Farber Cancer Institute |
2014-12-31 |
| NCT00511641 |
Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT00511641 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-02-29 |
| NCT00508378 |
Chemotherapy-Related Toxicities In Ovarian Cancer Patients |
https://ClinicalTrials.gov/show/NCT00508378 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-01-31 |
| NCT00499512 |
Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer |
https://ClinicalTrials.gov/show/NCT00499512 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-08-31 |
| NCT00488878 |
Data Collection for Patients With Low Grade Ovarian Carcinoma |
https://ClinicalTrials.gov/show/NCT00488878 |
Recruiting |
M.D. Anderson Cancer Center |
2034-05-31 |
| NCT00486707 |
Ovarian Cancer Patient Questionnaire on Genetic Testing |
https://ClinicalTrials.gov/show/NCT00486707 |
Completed |
M.D. Anderson Cancer Center |
2008-10-31 |
| NCT00478387 |
Ovarian Cancer and Immune Response to Flu Vaccine |
https://ClinicalTrials.gov/show/NCT00478387 |
Completed |
University of Pennsylvania |
2011-06-30 |
| NCT00368420 |
Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT00368420 |
Completed |
AGO Study Group |
2008-07-31 |
| NCT00345709 |
Elizabeth Registry for Low Grade Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT00345709 |
Completed |
M.D. Anderson Cancer Center |
2014-10-31 |
| NCT00315692 |
Risk of Ovarian Cancer in Patients With a Pelvic Mass |
https://ClinicalTrials.gov/show/NCT00315692 |
Completed |
Fujirebio Diagnostics, Inc. |
NA |
| NCT00004909 |
Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer |
https://ClinicalTrials.gov/show/NCT00004909 |
Completed |
Northwestern University |
2002-11-30 |
| NCT00003772 |
Quality-of-Life Assessment in Patients With Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT00003772 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2001-08-31 |
| NCT00005095 |
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention |
https://ClinicalTrials.gov/show/NCT00005095 |
Recruiting |
Northwestern University |
2020-12-31 |
| NCT00488202 |
Advanced Ovarian Cancer and Sexuality Phase 1 |
https://ClinicalTrials.gov/show/NCT00488202 |
Completed |
University of British Columbia |
2011-08-31 |
| NCT00001938 |
A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse) |
https://ClinicalTrials.gov/show/NCT00001938 |
Completed |
National Institutes of Health Clinical Center (CC) |
2012-12-31 |